# Duet Therapeutics, Inc. — Form D

Duet Therapeutics, Inc. of Skillman, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-08. The offering totals $1.0M, of which $200K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-03-08
- Form: D
- Accession: 0001968644-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $200K
- Remaining: $800K
- Investors: 1
- Date of first sale: 2022-12-16
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-475265

## Issuer

- Name: Duet Therapeutics, Inc.
- CIK: 0001968644
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 23 Southern Hills Dr., Skillman, NJ, 08558
- Phone: (609) 269-4659

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Simon Tomlinson | Director | Skillman, NJ |
| Simon Tomlinson | Executive Officer | Skillman, NJ |

## More

- [CIK 1968644 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1968644&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001968644-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.